{"version":"1.0","provider_name":"Synektik","provider_url":"https:\/\/synektik.com.pl\/en\/","title":"Synektik plans to divide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE - Synektik","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"a4ezweelSR\"><a href=\"https:\/\/synektik.com.pl\/en\/synektik-plans-to-divide\/\">Synektik plans to divide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/synektik.com.pl\/en\/synektik-plans-to-divide\/embed\/#?secret=a4ezweelSR\" width=\"600\" height=\"338\" title=\"&#8220;Synektik plans to divide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE&#8221; &#8212; Synektik\" data-secret=\"a4ezweelSR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/synektik.com.pl\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/synektik.com.pl\/wp-content\/uploads\/2023\/10\/Synektik_farmacja_szpitalna.jpg","thumbnail_width":1041,"thumbnail_height":800,"description":"Synektik, a provider of advanced solutions for medicine, including innovative medical devices and IT solutions, and the leading Polish producer of radiopharmaceuticals, intends to split into two independent companies. The listed firm plans to spin off the business connected with cardiotracer research into a new entity. This will open up new possibilities to raise financing [&hellip;]"}